Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. FTNT
4. QCOM
5. ARM
6. SBUX
7. TENB
8. CVNA
9. CMG
10. EQIX

Go back to Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors
(NASDAQ: APVO) Delayed: 3.90 -0.08 (2.01%)
Previous Close $3.98    52 Week High $4.33 
Open $4.09    52 Week Low $1.80 
Day High $4.09    P/E N/A 
Day Low $3.90    EPS $0.00 
Volume 8,431